長山人三

ナガヤマヒトミ | Nagayama Hitomi

研究分野 (1件)：血液、腫瘍内科学

研究キーワード (4件)：免疫療法 , 樹状細胞 , 造血幹細胞移植 , 臍帯血

競争的資金等の研究課題 (1件)：

2001 - 2002 臍帯血由来樹状細胞とCMV特異的ペプチドを用いたCMVワクチンの開発

論文 (46件)：

Takaaki Konuma, Akira Tomonari, Jun Ooi, Hitomi Nagayama, Toshiro Kawakita, Seiko Kato, Masamichi Isobe, Maki Monna-Oiwa, Arinobu Tojo, Yasuhito Nannya, et al. Thyrotoxicosis after unrelated cord blood transplantation for adults. Annals of hematology. 2022
Takaaki Konuma, Jun Ooi, Hitomi Nagayama, Akira Tomonari, Nobuhiro Tsukada, Seiko Kato, Toshiro Kawakita, Masamichi Isobe, Maki Monna-Oiwa, Arinobu Tojo, et al. Long-term outcomes following the addition of granulocyte colony-stimulating factor-combined high-dose cytarabine to total body irradiation and cyclophosphamide conditioning in single-unit cord blood transplantation for myeloid malignancies. Annals of Hematology. 2021
Matsuzawa Y, Adachi E, Takahashi A, Sato H, Lim LA, Komatsu T, Koibuchi T, Nagamura-Inoue T, Tojo A, Nagayama H, et al. Cytokine Profile in Sweet's Syndrome under the Treatment of Pulmonary Toxoplasmosis Complicated with Myelodysplastic Syndrome. Internal medicine (Tokyo, Japan). 2019. 58. 14. 2079-2083
Hitomi Nagayama, Kazufumi Matsumoto, Naoyuki Isoo, Hideki Ohno, Naoyuki Takahashi, Takashi Nakaoka, Masaru Shinozaki, Makoto Watanabe, Yusuke Inoue, Fumitaka Nagamura, et al. Gastrointestinal bleeding during anti-angiogenic peptide vaccination in combination with gemcitabine for advanced pancreatic cancer. Clinical Journal of Gastroenterology. 2010. 3. 6. 307-317
Tetsu Okumura, Hisayoshi Kondo, Hitomi Nagayama, Toshiro Makino, Toshiharu Yoshioka, Yasuhiro Yamamoto. Simple Triage and Rapid Decontamination of Mass Casualties with Colored Clothes Pegs (STARDOM-CCP) System against Chemical Releases. PREHOSPITAL AND DISASTER MEDICINE. 2007. 22. 3. 233-236

MISC (30件)：

T Nagamura-Inour, M Shioya, M Sugo, Y Cui, A Takahashi, K Takada, S Tomita, U Iwamoto, Y Tokushima, A Taguchi, et al. Factors influent on incidence and speed of engraftment of unrelated cord blood transplantation in 46 Japanese adult patients with units shipped from Tokyo Cord Blood Bank: Influence of the dose of CD 34+ cell and colony forming cells. BLOOD. 2002. 100. 11. 466B-467B
R Watanabe, S Okamoto, T Mori, H Nishida, Y Tsukada, N Sato, H Nagayama, N Takayama, Y Ikeda. Late-onset non-infectious pulmonary complications after allogeneic stem cell transplantation (SCT). BONE MARROW TRANSPLANTATION. 2002. 29. S178-S178
T Iguchi, S Okamoto, T Mori, R Watanabe, N Sato, H Nagayama, N Takayama, Y Ikeda. Risk factors of acute graft-versus-host disease (AGVHD) after allogeneic bone marrow transplantation using an matched unrelated donor (MUD) and prophylaxis with taclorimus (FK506) and methotrexate (MTX). BONE MARROW TRANSPLANTATION. 2002. 29. S172-S173
Y Tsukada, S Okamoto, T Mori, R Watanabe, T Iguchi, R Yamazaki, N Sato, H Nagayama, N Takayama, Y Ikeda. Long-term follow-up of allogeneic bone marrow transplantation after reduced-intensity conditioning in patients with chronic myelogenous leukemia in the chronic phase. BONE MARROW TRANSPLANTATION. 2002. 29. S162-S162
M Morishita, N Oyaizu, K Uchimaru, K Sato, H Nagayama, T Inazawa, T Nakaoka, E Akagawa, S Shimada, Y Kawakami, et al. Dendritic cell therapy for stage IV melanoma: Two cases of multiple tumor necrosis. BLOOD. 2001. 98. 11. 18A-19A

特許 (1件)：

細胞障害性T細胞誘導用組成物

学位 (2件)：

博士(医学) (東京大学)
医学士 (自治医科大学)

経歴 (2件)：

2021/04 - 2022/07 熊本大学国際先端医学研究機構客員教授
2018/04 - 2021/03 帝京大学ちば総合医療センター病院教授

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

長山 人三

長山人三